INTEGRIS Cancer Institute /ID# 200832
Oklahoma City, Oklahoma 73142
0 studies enrolling now · 1 studies all time
What they study most
Cancer
Studies at this site
A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
— Stopped early